UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Aldosterone a Relevant Factor in the Beginning and Evolution of Arterial Hypertension

American journal of hypertension, 2017-05, Vol.30 (5), p.468-469

2017

Volltextzugriff (PDF)

LCZ696, The Need for an Indication in Arterial Hypertension

American journal of hypertension, 2015-12, Vol.28 (12), p.1403-1404

2015

Volltextzugriff (PDF)

Association Between Awareness, Treatment, and Control of Hypertension, and Quality of Life Among Older Adults in Spain

American journal of hypertension, 2006-07, Vol.19 (7), p.686-693

2006

Volltextzugriff (PDF)

Beyond hypertension: Toward guidelines for cardiovascular risk reduction

American journal of hypertension, 2004-11, Vol.17 (11), p.1068-1074

2004

Volltextzugriff (PDF)

Erectile dysfunction in essential arterial hypertension and effects of sildenafil: results of a Spanish national study

American journal of hypertension, 2004-02, Vol.17 (2), p.139-145

2004

Volltextzugriff (PDF)

Kidney dysfunction: a sensitive predictor of cardiovascular risk

American journal of hypertension, 2001-06, Vol.14 (S3), p.213S-217S

Ruilope, Luis M.

2001

Volltextzugriff (PDF)

Hypertension guidelines: criteria that might make them more clinically useful

American Journal of Hypertension, 2002-10, Vol.15 (10), p.917-923

2002

Volltextzugriff (PDF)

Renoprotection and Renin-Angiotensin System Blockade in Diabetes Mellitus

American journal of hypertension, 1997-12, Vol.10 (S9), p.325S-331S

Ruilope, Luis M

1997

Volltextzugriff (PDF)

P-348: Control rates of blood pressure and proteinuria in patients with chronic renal insufficiency in Spain

American journal of hypertension, 2005-05, Vol.18 (S4), p.132A-132A

2005

Volltextzugriff (PDF)

P-181: Fixed-dose valsartan + hydrochlorothiazide combination therapy compared with amlodipine monotherapy in hypertensive patients with additional cardiovascular risk factors: The vast study

American journal of hypertension, 2005-05, Vol.18 (S4), p.72A-73A

2005

Volltextzugriff (PDF)

P-515: Do current clinical management provide enough protection in hypertensive patients with metabolic syndrome?

American journal of hypertension, 2005-05, Vol.18 (S4), p.194A-195A

2005

Volltextzugriff (PDF)

P-125: Could serum urate changes after diuretic therapy predict an elevated cardiovascular risk?

American journal of hypertension, 2005-05, Vol.18 (S4), p.53A-53A

2005

Volltextzugriff (PDF)

P-151: Correlation between estimated glomerular filtration rate and microalbuminuria in treated essential hypertensive patients

American journal of hypertension, 2004-05, Vol.17 (S1), p.89A-89A

2004

Volltextzugriff (PDF)

Ace inhibition and cardiovascular mortality and morbidity in essential hypertension: The end of the search or a need for further investigations?

American journal of hypertension, 2002-04, Vol.15 (4), p.367-371

2002

Volltextzugriff (PDF)

P-264: The association between fasting plasma glucose and subclinical vascular damage in essential hypertension do not improve with the presence of metabolic syndrome criteria

American journal of hypertension, 2004-05, Vol.17 (S1), p.128A-129A

2004

Volltextzugriff (PDF)

P-370: Management of high-risk hypertensive patients in Spain. The Tarvest study

American journal of hypertension, 2005-05, Vol.18 (S4), p.140A-140A

2005

Volltextzugriff (PDF)

P-182: 24 hours natriuresis estimations with a spot urine sample in hypertensive population. Is clinically useful?

American journal of hypertension, 2003-05, Vol.16 (S1), p.105A-105A

2003

Volltextzugriff (PDF)

P-182: 24-hour ambulatory blood-pressure effects of valsartan + hydrochlorothiazide combinations compared with amlodipine in hypertensive patients at increased cardiovascular risk

American journal of hypertension, 2005-05, Vol.18 (S4), p.73A-73A

2005

Volltextzugriff (PDF)

P-217: Blood pressure control does not ensure the control of microalbuminuria in previously untreated hypertension

American journal of hypertension, 2001-04, Vol.14 (S1), p.101A-101A

2001

Volltextzugriff (PDF)

P-152: Prevalence and incidence of urinary sediment alterations in hypertensive patients

American journal of hypertension, 2004-05, Vol.17 (S1), p.89A-89A

2004

Volltextzugriff (PDF)

P-168: Development of chronic kidney disease and cardiovascular prognosis in long-term treated hypertensive patients

American journal of hypertension, 2004-05, Vol.17 (S1), p.94A-94A

2004

Volltextzugriff (PDF)

P-46: Treatment compliance with lercanidipine. electra study

American journal of hypertension, 2002-04, Vol.15 (S3), p.50A-50A

2002

Volltextzugriff (PDF)

P-248: Is combined antihypertensive therapy enough to achieve adequate blood pressure control?

American journal of hypertension, 2004-05, Vol.17 (S1), p.123A-123A

2004

Volltextzugriff (PDF)

P-16: Smoothness index obtained by lercanidipine therapy strongly correlates with left ventricular mass changes in essential hypertension: A prospective study

American journal of hypertension, 2003-05, Vol.16 (S1), p.45A-45A

2003

Volltextzugriff (PDF)

P-163: High number of blood pressure measurements at office offers an accuracy detection of isolated office hypertension

American journal of hypertension, 2002-04, Vol.15 (S3), p.88A-88A

2002

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Aktive Filter

ThemaBlood Pressure - Drug Effects

Zeitschrift / SerieAmerican Journal Of Hypertension

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(101)

Sprache

Englisch
(101)

Erscheinungsjahr

n.n

Thema

Peripheral Vascular Disease
(20)
Cardiovascular System & Cardiology
(18)
Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Hypertension
(14)
Humans
(12)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Cardiovascular Risk
(9)
Risk Factors
(8)
Cardiology. Vascular System
(7)
Proteinuria
(7)
Renal Function
(7)
Animals
(6)
Arterial Hypertension. Arterial Hypotension
(6)
Blood And Lymphatic Vessels
(6)
Male
(6)
Microalbuminuria
(6)
Blood Pressure
(5)
Hypertension - Complications
(5)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Oxford University Press Journals Current
(101)
Oxford Journals 2020 Medicine
(101)
Journals@Ovid Full Text
(101)
IngentaConnect
(101)
IngentaConnect Journals
(55)
MEDLINE
(16)

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Aldosterone a Relevant Factor in the Beginning and Evolution of Arterial Hypertension

LCZ696, The Need for an Indication in Arterial Hypertension

Association Between Awareness, Treatment, and Control of Hypertension, and Quality of Life Among Older Adults in Spain

Beyond hypertension: Toward guidelines for cardiovascular risk reduction

Erectile dysfunction in essential arterial hypertension and effects of sildenafil: results of a Spanish national study

Kidney dysfunction: a sensitive predictor of cardiovascular risk

Hypertension guidelines: criteria that might make them more clinically useful

Renoprotection and Renin-Angiotensin System Blockade in Diabetes Mellitus

P-348: Control rates of blood pressure and proteinuria in patients with chronic renal insufficiency in Spain

P-181: Fixed-dose valsartan + hydrochlorothiazide combination therapy compared with amlodipine monotherapy in hypertensive patients with additional cardiovascular risk factors: The vast study

P-515: Do current clinical management provide enough protection in hypertensive patients with metabolic syndrome?

P-125: Could serum urate changes after diuretic therapy predict an elevated cardiovascular risk?

P-151: Correlation between estimated glomerular filtration rate and microalbuminuria in treated essential hypertensive patients

Ace inhibition and cardiovascular mortality and morbidity in essential hypertension: The end of the search or a need for further investigations?

P-264: The association between fasting plasma glucose and subclinical vascular damage in essential hypertension do not improve with the presence of metabolic syndrome criteria

P-370: Management of high-risk hypertensive patients in Spain. The Tarvest study

P-182: 24 hours natriuresis estimations with a spot urine sample in hypertensive population. Is clinically useful?

P-182: 24-hour ambulatory blood-pressure effects of valsartan + hydrochlorothiazide combinations compared with amlodipine in hypertensive patients at increased cardiovascular risk

P-217: Blood pressure control does not ensure the control of microalbuminuria in previously untreated hypertension

P-152: Prevalence and incidence of urinary sediment alterations in hypertensive patients

P-168: Development of chronic kidney disease and cardiovascular prognosis in long-term treated hypertensive patients

P-46: Treatment compliance with lercanidipine. electra study

P-248: Is combined antihypertensive therapy enough to achieve adequate blood pressure control?

P-16: Smoothness index obtained by lercanidipine therapy strongly correlates with left ventricular mass changes in essential hypertension: A prospective study

P-163: High number of blood pressure measurements at office offers an accuracy detection of isolated office hypertension

Aktive Filter

Suchergebnisse filtern